BioCryst Pharmaceuticals, Inc.
US ˙ NasdaqGS ˙ US09058V1035

Pengenalan

Halaman ini menyediakan analisis menyeluruh tentang sejarah dagangan orang dalam yang diketahui Thomas R Ii Staab. Orang dalam ialah pegawai, pengarah atau pelabur penting dalam syarikat. Adalah haram bagi orang dalam untuk membuat perdagangan dalam syarikat mereka berdasarkan maklumat khusus bukan awam. Ini tidak bermakna haram bagi mereka untuk membuat sebarang perdagangan dalam syarikat mereka sendiri. Tetapi mereka mesti melaporkan semua perdagangan kepada SEC melalui Borang 4. Walaupun terdapat sekatan ini, penyelidikan akademik menunjukkan bahawa orang dalam - secara amnya - cenderung untuk mengatasi prestasi pasaran dalam syarikat mereka sendiri.

Purata Keuntungan Perdagangan

Purata keuntungan perdagangan ialah purata pulangan semua pembelian pasaran terbuka yang dibuat oleh orang dalam dalam tempoh tiga tahun terakhir. Untuk mengira ini, kami memeriksa setiap pembelian pasaran terbuka yang tidak dirancang oleh orang dalam, tidak termasuk semua dagangan yang ditandakan sebagai sebahagian daripada pelan dagangan 10b5-1. Kami kemudian mengira prestasi purata dagangan tersebut sepanjang 3, 6 dan 12 bulan, dengan purata setiap tempoh tersebut untuk menjana metrik prestasi akhir bagi setiap dagangan. Akhir sekali, kami puratakan semua metrik prestasi untuk mengira metrik prestasi untuk orang dalam. Senarai ini hanya termasuk orang dalam yang telah membuat sekurang-kurangnya tiga dagangan dalam dua tahun lepas.

Jika keuntungan berdagang orang dalam ini ialah "N/A", maka orang dalam sama ada tidak membuat sebarang pembelian pasaran terbuka dalam tempoh tiga tahun terakhir, atau dagangan yang mereka buat adalah terlalu baru untuk mengira metrik prestasi yang boleh dipercayai.

Kekerapan Kemas Kini: Harian

Lihat senarai pedagang dalaman yang paling menguntungkan.

Syarikat dengan Kedudukan Orang Dalam yang Dilaporkan

Pemfailan SEC menunjukkan Thomas R Ii Staab telah melaporkan pegangan atau perdagangan dalam syarikat berikut:

Sekuriti Tajuk Pegangan Terkini Dilaporkan
US:LNSR / LENSAR, Inc. Chief Financial Officer 173,361
US:BCRX / BioCryst Pharmaceuticals, Inc. Senior Vice President and CFO 18,000
Bagaimana Mentafsir Carta

Carta berikut menunjukkan prestasi saham sekuriti selepas setiap dagangan pasaran terbuka dan tidak dirancang yang dibuat oleh Thomas R Ii Staab. Perdagangan tidak dirancang ialah dagangan yang tidak dibuat sebagai sebahagian daripada pelan dagangan 10b5-1. Prestasi saham dicatatkan sebagai perubahan peratus kumulatif dalam harga saham. Sebagai contoh, jika perdagangan orang dalam dibuat pada 1 Januari 2019, carta akan menunjukkan perubahan peratusan harian sekuriti kepada hari ini. Jika harga saham naik dari $10 kepada $15 pada masa ini, perubahan peratus terkumpul dalam harga saham ialah 50%. Perubahan dalam harga daripada $10 kepada $20 ialah 100% dan perubahan dalam harga $10 hingga $5 ialah -50%.

Secara dasarnya, kami cuba untuk menentukan sejauh mana dagangan orang dalam berkait rapat dengan pulangan berlebihan (positif atau negatif) dalam harga saham untuk melihat sama ada orang dalam menetapkan masa dagangan mereka untuk mendapat keuntungan daripada maklumat orang dalam. Pertimbangkan situasi di mana orang dalam melakukan perkara ini. Dalam keadaan ini, kami menjangkakan sama ada (a) pulangan positif selepas pembelian, atau (b) pulangan negatif selepas jualan. Dalam kes (a), carta PEMBELIAN akan menunjukkan satu siri keluk condong ke atas, menunjukkan pulangan positif selepas setiap transaksi pembelian. Dalam kes (b), carta JUALAN akan menunjukkan satu siri keluk condong ke bawah, menunjukkan pulangan negatif selepas setiap transaksi jualan.

Walau bagaimanapun, ini sahaja tidak cukup untuk membuat kesimpulan. Jika, sebagai contoh, harga saham syarikat berada dalam pendakian bukan disebabkan kitaran selama bertahun-tahun, maka kami menjangkakan semua plot selepas pembelian akan condong ke atas. Begitu juga, kemerosotan bukan disebabkan kitaran selama bertahun-tahun akan mengakibatkan plot pasca perdagangan condong ke bawah. Kedua-dua carta ini tidak akan mencadangkan aktiviti perdagangan orang dalam.

Penunjuk terkuat ialah keadaan di mana harga saham adalah sangat kitaran, dan terdapat kedua-dua isyarat positif dalam carta PEMBELIAN dan plot negatif pada carta JUALAN. Situasi ini akan sangat menunjukkan orang dalam yang menentukan masa perdagangan untuk kelebihan kewangan mereka.

Pembelian Orang Dalam BCRX / BioCryst Pharmaceuticals, Inc. - Analisis Keuntungan Jangka Pendek

Dalam bahagian ini, kami menganalisis keuntungan setiap pembelian orang dalam pasaran terbuka yang tidak dirancang yang dibuat dalam BCRX / BioCryst Pharmaceuticals, Inc.. Analisis ini membantu untuk memahami sama ada orang dalam secara konsisten menjana pulangan tidak normal dan patut diikuti. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah bersifat teori .

Jadual berikut menunjukkan pembelian pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.

Tarikh Dagangan Simbol Saham Orang dalam Saham
Dilaporkan
Harga
Dilaporkan
Saham
Dilaraskan
Harga
Dilaraskan
Asas Kos Hari ke
Maks
Harga pada
Maks
Maks
Keuntungan ($)
Pulangan Maks (%)
Tiada dagangan pasaran terbuka tidak dirancang yang tidak diketahui untuk gabungan orang dalam dan sekuriti ini

Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.

BCRX / BioCryst Pharmaceuticals, Inc. Insider Trades
Jualan Orang Dalam BCRX / BioCryst Pharmaceuticals, Inc. - Analisis Kerugian Jangka Pendek

Dalam bahagian ini, kami menganalisis pengelakan kerugian jangka pendek bagi setiap jualan dalaman pasaran terbuka yang tidak dirancang yang dibuat dalam BCRX / BioCryst Pharmaceuticals, Inc.. Corak pengelakan kerugian yang konsisten mungkin mencadangkan bahawa urus niaga jualan masa hadapan mungkin meramalkan penurunan harga. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah teori .

Jadual berikut menunjukkan jualan pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.

Tarikh Dagangan Simbol Saham Orang dalam Saham
Dilaporkan
Harga
Dilaporkan
Saham
Dilaraskan
Harga
Dilaraskan
Asas Kos Hari ke
Min
Harga pada
Min
Kerugian Maks
Dielakkan ($)
Kerugian Maks
Dielakkan (%)
2018-12-04 BCRX STAAB THOMAS R II 3,922 9.4500 3,922 9.4500 37,063 345 1.585 -30,846 -83.23
2016-08-12 BCRX STAAB THOMAS R II 4,558 5.2200 4,558 5.2200 23,793
2016-08-11 BCRX STAAB THOMAS R II 1,306 5.0500 1,306 5.0500 6,595
2016-08-09 BCRX STAAB THOMAS R II 14,577 4.4300 14,577 4.4300 64,576
2015-12-21 BCRX STAAB THOMAS R II 3,052 10.8600 3,052 10.8600 33,145
2015-12-17 BCRX STAAB THOMAS R II 3,000 10.4900 3,000 10.4900 31,470
2014-12-29 BCRX STAAB THOMAS R II 9,500 12.5600 9,500 12.5600 119,320
2014-08-27 BCRX STAAB THOMAS R II 10,000 13.5800 10,000 13.5800 135,800
2014-03-14 BCRX STAAB THOMAS R II 3,125 11.2400 3,125 11.2400 35,125
2014-03-04 BCRX STAAB THOMAS R II 3,000 12.6900 3,000 12.6900 38,070

Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.

BCRX / BioCryst Pharmaceuticals, Inc. Insider Trades
Pembelian Orang Dalam LNSR / LENSAR, Inc. - Analisis Keuntungan Jangka Pendek

Dalam bahagian ini, kami menganalisis keuntungan setiap pembelian orang dalam pasaran terbuka yang tidak dirancang yang dibuat dalam BCRX / BioCryst Pharmaceuticals, Inc.. Analisis ini membantu untuk memahami sama ada orang dalam secara konsisten menjana pulangan tidak normal dan patut diikuti. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah bersifat teori .

Jadual berikut menunjukkan pembelian pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.

Tarikh Dagangan Simbol Saham Orang dalam Saham
Dilaporkan
Harga
Dilaporkan
Saham
Dilaraskan
Harga
Dilaraskan
Asas Kos Hari ke
Maks
Harga pada
Maks
Maks
Keuntungan ($)
Pulangan Maks (%)
2022-12-07 LNSR STAAB THOMAS R II 727 3.1560 727 3.1560 2,294 210 4.41 912 39.76
2022-12-06 LNSR STAAB THOMAS R II 2,025 3.1620 2,025 3.1620 6,403

Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.

LNSR / LENSAR, Inc. Insider Trades
Jualan Orang Dalam LNSR / LENSAR, Inc. - Analisis Kerugian Jangka Pendek

Dalam bahagian ini, kami menganalisis pengelakan kerugian jangka pendek bagi setiap jualan dalaman pasaran terbuka yang tidak dirancang yang dibuat dalam BCRX / BioCryst Pharmaceuticals, Inc.. Corak pengelakan kerugian yang konsisten mungkin mencadangkan bahawa urus niaga jualan masa hadapan mungkin meramalkan penurunan harga. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah teori .

Jadual berikut menunjukkan jualan pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.

Tarikh Dagangan Simbol Saham Orang dalam Saham
Dilaporkan
Harga
Dilaporkan
Saham
Dilaraskan
Harga
Dilaraskan
Asas Kos Hari ke
Min
Harga pada
Min
Kerugian Maks
Dielakkan ($)
Kerugian Maks
Dielakkan (%)
Tiada dagangan pasaran terbuka tidak dirancang yang tidak diketahui untuk gabungan orang dalam dan sekuriti ini

Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.

LNSR / LENSAR, Inc. Insider Trades
Sejarah Dagangan Orang Dalam

Jadual ini menunjukkan senarai lengkap dagangan orang dalam yang dibuat oleh Thomas R Ii Staab seperti yang didedahkan kepada Suruhanjaya Bursa Sekuriti (SEC).

Tarikh Fail Tarikh Tran Borang Simbol Saham Sekuriti Kod 10b5-1 Saham Baki Saham Peratus
Ubah
Saham
harga
Tran
Nilai
Baki
Nilai
2025-02-20 2025-02-18 4 LNSR LENSAR, Inc.
Common Stock
A - Award 12,766 173,361 7.95
2025-02-06 2025-01-11 4 LNSR LENSAR, Inc.
Common Stock
F - Taxes -1,839 160,595 -1.13 8.25 -15,172 1,324,909
2024-08-12 2024-08-08 4 LNSR LENSAR, Inc.
Common Stock
M - Exercise 3,500 162,434 2.20 2.65 9,275 430,450
2024-05-08 2024-05-06 4 LNSR LENSAR, Inc.
Common Stock
A - Award 19,000 158,934 13.58
2024-05-08 2024-01-11 4 LNSR LENSAR, Inc.
Common Stock
F - Taxes -1,853 139,934 -1.31 4.43 -8,209 619,908
2023-01-13 2023-01-11 4 LNSR LENSAR, Inc.
Common Stock
A - Award 6,656 141,787 4.93
2022-12-07 2022-12-07 4 LNSR LENSAR, Inc.
Common Stock
P - Purchase 727 135,131 0.54 3.16 2,294 426,473
2022-12-07 2022-12-06 4 LNSR LENSAR, Inc.
Common Stock
P - Purchase 2,025 134,404 1.53 3.16 6,403 424,985
2022-01-13 2022-01-11 4 LNSR LENSAR, Inc.
Stock Option (Right to Buy)
A - Award 52,500 52,500
2022-01-13 2022-01-11 4 LNSR LENSAR, Inc.
Common Stock
A - Award 15,000 131,409 12.89
2021-04-14 2021-04-12 4 LNSR LENSAR, Inc.
Stock Option (Right to Buy)
A - Award 49,197 49,197
2020-12-10 2020-12-07 4 LNSR LENSAR, Inc.
Common Stock
A - Award 19,276 115,657 20.00
2020-09-17 3 LNSR LENSAR, Inc.
Common Stock
96,381
2020-02-25 2020-02-21 4 BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
A - Award 18,000 18,000
2020-02-19 2020-02-14 4 BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
A - Award 31,500 31,500
2019-12-26 2019-12-17 4/A BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
A - Award 127,000 127,000
2019-12-19 2019-12-17 4 BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
A - Award 165,000 165,000
2019-05-20 2019-05-17 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
S - Sale X -2,500 125,176 -1.96 7.45 -18,625 932,561
2019-05-20 2019-05-16 4 BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
M - Exercise X -4,750 61,000 -7.22
2019-05-20 2019-05-16 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
S - Sale X -7,250 127,676 -5.37 7.72 -55,970 985,659
2019-05-20 2019-05-16 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
M - Exercise X 4,750 134,926 3.65 1.42 6,745 191,595
2019-05-16 2019-05-15 4 BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
M - Exercise X -4,750 65,750 -6.74
2019-05-16 2019-05-15 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
S - Sale X -7,250 130,176 -5.28 7.92 -57,420 1,030,994
2019-05-16 2019-05-15 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
M - Exercise X 4,750 137,426 3.58 1.42 6,745 195,145
2019-05-16 2019-05-14 4 BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
M - Exercise X -4,500 70,500 -6.00
2019-05-16 2019-05-14 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
S - Sale X -4,500 132,676 -3.28 7.62 -34,290 1,010,991
2019-05-16 2019-05-14 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
M - Exercise X 4,500 137,176 3.39 1.42 6,390 194,790
2019-05-13 2019-05-13 4 BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
M - Exercise X -9,750 131,250 -6.91
2019-05-13 2019-05-13 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
S - Sale X -9,750 132,676 -6.85 7.76 -75,660 1,029,566
2019-05-13 2019-05-13 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
M - Exercise X 9,750 142,426 7.35 5.51 53,722 784,767
2019-05-13 2019-05-09 4 BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
M - Exercise X -9,750 141,000 -6.47
2019-05-13 2019-05-09 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
S - Sale X -9,750 132,676 -6.85 7.63 -74,392 1,012,318
2019-05-13 2019-05-09 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
M - Exercise X 9,750 142,426 7.35 5.51 53,722 784,767
2019-05-06 2019-05-06 4 BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
M - Exercise X -9,000 150,750 -5.63
2019-05-06 2019-05-06 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
S - Sale X -9,000 132,676 -6.35 7.75 -69,750 1,028,239
2019-05-06 2019-05-06 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
M - Exercise X 9,000 141,676 6.78 5.51 49,590 780,635
2019-05-06 2019-05-02 4 BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
M - Exercise X -7,750 159,750 -4.63
2019-05-06 2019-05-02 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
S - Sale X -7,750 132,676 -5.52 7.30 -56,575 968,535
2019-05-06 2019-05-02 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
M - Exercise X 7,750 140,426 5.84 5.51 42,702 773,747
2019-04-08 2019-04-04 4 BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
M - Exercise X -7,500 167,500 -4.29
2019-04-08 2019-04-04 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
S - Sale X -7,500 132,676 -5.35 8.81 -66,075 1,168,876
2019-04-08 2019-04-04 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
M - Exercise X 7,500 140,176 5.65 5.51 41,325 772,370
2019-01-30 2019-01-28 4 BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
M - Exercise X -5,000 7,000 -41.67
2019-01-30 2019-01-28 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
S - Sale X -5,000 128,426 -3.75 9.85 -49,250 1,264,996
2019-01-30 2019-01-28 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
M - Exercise X 5,000 133,426 3.89 5.45 27,250 727,172
2019-01-03 2019-01-01 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
F - Taxes -785 132,676 -0.59 8.07 -6,335 1,070,695
2018-12-21 2018-12-20 4 BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
A - Award 235,000 235,000
2018-12-06 2018-12-04 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
S - Sale -3,922 133,461 -2.85 9.45 -37,063 1,261,206
2018-11-26 2018-11-23 4 BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
M - Exercise X -3,500 28,305 -11.00
2018-11-26 2018-11-23 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
S - Sale X -3,500 137,383 -2.48 9.66 -33,810 1,327,120
2018-11-26 2018-11-23 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
M - Exercise X 3,500 140,883 2.55 3.78 13,230 532,538
2018-11-26 2018-11-21 4 BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
M - Exercise X -7,000 31,805 -18.04
2018-11-26 2018-11-21 4 BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
M - Exercise X -5,000 12,000 -29.41
2018-11-26 2018-11-21 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
S - Sale X -7,000 137,383 -4.85 9.08 -63,560 1,247,438
2018-11-26 2018-11-21 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
M - Exercise X 7,000 144,383 5.10 3.78 26,460 545,768
2018-11-26 2018-11-21 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
S - Sale X -5,000 137,383 -3.51 9.41 -47,050 1,292,774
2018-11-26 2018-11-21 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
M - Exercise X 5,000 142,383 3.64 5.45 27,250 775,987
2018-11-21 2018-11-20 4 BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
M - Exercise X -6,500 97,071 -6.28
2018-11-21 2018-11-20 4 BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
M - Exercise X -4,623 38,805 -10.65
2018-11-21 2018-11-20 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
S - Sale X -6,500 137,383 -4.52 8.75 -56,875 1,202,101
2018-11-21 2018-11-20 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
M - Exercise X 6,500 143,883 4.73 3.22 20,930 463,303
2018-11-21 2018-11-20 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
S - Sale X -4,623 137,383 -3.26 8.57 -39,619 1,177,372
2018-11-21 2018-11-20 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
M - Exercise X 4,623 142,006 3.37 3.78 17,475 536,783
2018-11-21 2018-11-19 4 BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
M - Exercise X -75 43,428 -0.17
2018-11-21 2018-11-19 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
S - Sale X -75 137,383 -0.05 8.30 -622 1,140,279
2018-11-21 2018-11-19 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
M - Exercise X 75 137,458 0.05 3.78 284 519,591
2018-11-09 2018-11-08 4 BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
M - Exercise X -2,302 43,503 -5.03
2018-11-09 2018-11-08 4 BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
M - Exercise X -11,113 103,571 -9.69
2018-11-09 2018-11-08 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
S - Sale X -2,302 137,383 -1.65 8.30 -19,107 1,140,279
2018-11-09 2018-11-08 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
M - Exercise X 2,302 139,685 1.68 3.78 8,702 528,009
2018-11-09 2018-11-08 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
S - Sale X -11,113 137,383 -7.48 8.09 -89,904 1,111,428
2018-11-09 2018-11-08 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
M - Exercise X 11,113 148,496 8.09 3.22 35,784 478,157
2018-11-09 2018-11-07 4 BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
M - Exercise X -672 114,684 -0.58
2018-11-09 2018-11-07 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
S - Sale X -672 137,383 -0.49 8.00 -5,376 1,099,064
2018-11-09 2018-11-07 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
M - Exercise X 672 138,055 0.49 3.22 2,164 444,537
2018-11-07 2018-11-05 4 BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
M - Exercise X -215 115,356 -0.19
2018-11-07 2018-11-05 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
S - Sale X -215 137,383 -0.16 8.00 -1,720 1,099,064
2018-11-07 2018-11-05 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
M - Exercise X 215 137,598 0.16 3.22 692 443,066
2018-11-06 2018-11-02 4 BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
M - Exercise X -3,500 45,805 -7.10
2018-11-06 2018-11-02 4 BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
M - Exercise X -7,356 115,571 -5.98
2018-11-06 2018-11-02 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
S - Sale X -3,500 137,383 -2.48 7.96 -27,860 1,093,569
2018-11-06 2018-11-02 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
M - Exercise X 3,500 140,883 2.55 3.78 13,230 532,538
2018-11-06 2018-11-02 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
S - Sale X -7,356 137,383 -5.08 7.78 -57,230 1,068,840
2018-11-06 2018-11-02 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
M - Exercise X 7,356 144,739 5.35 3.22 23,686 466,060
2018-10-23 2018-10-19 4 BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
M - Exercise X -3,150 49,305 -6.01
2018-10-23 2018-10-19 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
S - Sale X -3,150 137,383 -2.24 7.45 -23,468 1,023,503
2018-10-23 2018-10-19 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
M - Exercise X 3,150 140,533 2.29 3.78 11,907 531,215
2018-10-04 2018-10-03 4 BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
M - Exercise X -100 52,455 -0.19
2018-10-04 2018-10-03 4 BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
M - Exercise X -972 122,927 -0.78
2018-10-04 2018-10-03 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
S - Sale X -100 137,383 -0.07 7.45 -745 1,023,503
2018-10-04 2018-10-03 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
M - Exercise X 100 137,483 0.07 3.78 378 519,686
2018-10-04 2018-10-03 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
S - Sale X -972 137,383 -0.70 7.26 -7,057 997,401
2018-10-04 2018-10-03 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
M - Exercise X 972 138,355 0.71 3.22 3,130 445,503
2018-10-04 2018-10-02 4 BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
M - Exercise X -5,528 123,899 -4.27
2018-10-04 2018-10-02 4 BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
M - Exercise X -3,250 52,555 -5.82
2018-10-04 2018-10-02 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
S - Sale X -5,528 137,383 -3.87 7.27 -40,189 998,774
2018-10-04 2018-10-02 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
M - Exercise X 5,528 142,911 4.02 3.22 17,800 460,173
2018-10-04 2018-10-02 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
S - Sale X -3,250 137,383 -2.31 7.19 -23,368 987,784
2018-10-04 2018-10-02 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
M - Exercise X 3,250 140,633 2.37 3.78 12,285 531,593
2018-01-23 2018-01-20 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
F - Taxes -3,979 137,383 -2.81 5.59 -22,243 767,971
2018-01-03 2018-01-01 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
F - Taxes -852 141,362 -0.60 4.91 -4,183 694,087
2017-12-22 2017-12-20 4 BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
A - Award 100,000 100,000
2017-09-05 2017-08-31 4 BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
A - Award 27,000 27,000
2017-05-24 2017-05-22 4 BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
M - Exercise -7,750 4,000 -65.96
2017-05-24 2017-05-22 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
F - Taxes -6,996 142,214 -4.69 5.24 -36,659 745,201
2017-05-24 2017-05-22 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
M - Exercise 7,750 149,210 5.48 4.73 36,658 705,763
2017-03-22 2017-03-20 4 BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
M - Exercise -3,250 55,805 -5.50
2017-03-22 2017-03-20 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
S - Sale X -3,250 141,460 -2.25 9.20 -29,900 1,301,432
2017-03-22 2017-03-20 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
M - Exercise X 3,250 144,710 2.30 3.78 12,285 547,004
2017-03-20 2017-03-16 4 BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
M - Exercise -12,500 75,000 -14.29
2017-03-20 2017-03-16 4 BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
M - Exercise -23,955 59,055 -28.86
2017-03-20 2017-03-16 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
F - Taxes -12,308 141,460 -8.00 8.80 -108,310 1,244,848
2017-03-20 2017-03-16 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
M - Exercise 12,500 153,768 8.85 1.42 17,750 218,351
2017-03-20 2017-03-16 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
M - Exercise 23,955 141,268 20.42 3.78 90,550 533,993
2017-03-14 2017-03-10 4 BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
M - Exercise -3,250 83,010 -3.77
2017-03-14 2017-03-10 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
S - Sale X -3,250 117,313 -2.70 9.06 -29,445 1,062,856
2017-03-14 2017-03-10 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
M - Exercise X 3,250 120,563 2.77 3.78 12,285 455,728
2017-03-10 2017-03-08 4 BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
M - Exercise -6,500 86,260 -7.01
2017-03-10 2017-03-08 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
S - Sale X -3,250 117,313 -2.70 8.65 -28,112 1,014,757
2017-03-10 2017-03-08 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
S - Sale X -3,250 120,563 -2.62 8.20 -26,650 988,617
2017-03-10 2017-03-08 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
M - Exercise X 6,500 123,813 5.54 3.78 24,570 468,013
2017-03-08 2017-03-06 4 BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
M - Exercise -3,250 92,760 -3.39
2017-03-08 2017-03-06 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
S - Sale X -3,250 117,313 -2.70 7.90 -25,675 926,773
2017-03-08 2017-03-06 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
M - Exercise X 3,250 120,563 2.77 3.78 12,285 455,728
2017-03-01 2017-02-27 4 BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
A - Award 175,000 175,000
2017-01-24 2017-01-20 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
F - Taxes -5,198 117,313 -4.24 5.95 -30,928 698,012
2017-01-03 2017-01-01 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
F - Taxes -1,676 122,511 -1.35 6.33 -10,609 775,495
2016-12-21 2016-12-19 4 BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
M - Exercise -3,250 96,010 -3.27
2016-12-21 2016-12-19 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
S - Sale X -3,250 124,187 -2.55 7.45 -24,212 925,193
2016-12-21 2016-12-19 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
M - Exercise X 3,250 127,437 2.62 3.78 12,285 481,712
2016-08-15 2016-08-12 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
S - Sale -4,558 124,187 -3.54 5.22 -23,793 648,256
2016-08-15 2016-08-11 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
S - Sale -1,306 128,745 -1.00 5.05 -6,595 650,162
2016-08-11 2016-08-09 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
S - Sale -14,577 130,051 -10.08 4.43 -64,576 576,126
2016-05-25 2016-05-23 4 BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
A - Award 129,427 129,427
2016-03-03 2016-03-01 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
F - Taxes -465 144,628 -0.32 2.13 -990 308,058
2016-01-22 2016-01-20 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
F - Taxes -4,823 145,093 -3.22 7.55 -36,414 1,095,452
2016-01-21 2016-01-19 4 BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
M - Exercise -12,500 87,500 -12.50
2016-01-21 2016-01-19 4 BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
M - Exercise -2,500 99,260 -2.46
2016-01-21 2016-01-19 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
M - Exercise 12,500 149,916 9.10 1.42 17,750 212,881
2016-01-21 2016-01-19 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
M - Exercise 2,500 137,416 1.85 3.78 9,450 519,432
2016-01-05 2016-01-01 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
F - Taxes -1,676 134,916 -1.23 10.32 -17,296 1,392,333
2015-12-31 2015-12-29 4 BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
A - Award 62,573 62,573
2015-12-22 2015-12-21 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
S - Sale -3,052 136,592 -2.19 10.86 -33,145 1,483,389
2015-12-18 2015-12-17 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
S - Sale -3,000 139,644 -2.10 10.49 -31,470 1,464,866
2015-07-22 2015-07-20 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
S - Sale X -3,500 142,644 -2.39 16.50 -57,750 2,353,626
2015-06-24 2015-06-22 4 BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
M - Exercise X -3,750 11,750 -24.19
2015-06-24 2015-06-22 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
S - Sale X -3,750 146,144 -2.50 16.00 -60,000 2,338,304
2015-06-24 2015-06-22 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
M - Exercise X 3,750 149,894 2.57 4.73 17,738 708,999
2015-06-22 2015-06-19 4 BCRX BIOCRYST PHARMACEUTICALS INC
Stock Option (Right to Buy)
M - Exercise X -3,175 101,760 -3.03
2015-06-22 2015-06-19 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
S - Sale X -3,175 146,144 -2.13 15.00 -47,625 2,192,160
2015-06-22 2015-06-19 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
M - Exercise X 3,175 149,319 2.17 3.78 12,002 564,426
2015-06-22 2015-06-19 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
S - Sale X -3,500 146,144 -2.34 15.00 -52,500 2,192,160
2015-06-22 2015-06-18 4 BCRX BIOCRYST PHARMACEUTICALS INC
Stock Option (Right to Buy)
M - Exercise X -3,100 104,935 -2.87
2015-06-22 2015-06-18 4 BCRX BIOCRYST PHARMACEUTICALS INC
Stock Option (Right to Buy)
M - Exercise X -3,100 104,935 -2.87
2015-06-22 2015-06-18 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
S - Sale X -3,100 149,644 -2.03 13.50 -41,850 2,020,194
2015-06-22 2015-06-18 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
S - Sale X -3,100 152,744 -1.99 14.25 -44,175 2,176,602
2015-06-22 2015-06-18 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
M - Exercise X 3,100 155,844 2.03 3.78 11,718 589,090
2015-06-22 2015-06-18 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
M - Exercise X 3,100 155,844 2.03 3.78 11,718 589,090
2015-06-22 2015-06-18 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
S - Sale X -3,500 149,644 -2.29 14.00 -49,000 2,095,016
2015-06-16 2015-05-13 4 BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
A - Award 17,000 17,000
2015-06-09 2015-06-05 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
S - Sale X -6,000 153,144 -3.77 12.75 -76,500 1,952,586
2015-06-02 2015-06-01 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
S - Sale X -3,000 159,144 -1.85 12.00 -36,000 1,909,728
2015-05-19 2015-05-18 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
S - Sale X -3,000 162,144 -1.82 11.00 -33,000 1,783,584
2015-03-03 2015-03-01 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
F - Taxes -465 165,144 -0.28 10.20 -4,743 1,684,469
2015-01-22 2015-01-20 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
F - Taxes -4,476 164,913 -2.64 11.17 -49,997 1,842,078
2015-01-05 2015-01-01 4 BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
A - Award 42,400 42,400
2015-01-05 2015-01-01 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
F - Taxes -2,453 169,389 -1.43 12.16 -29,828 2,059,770
2015-01-05 2015-01-01 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
A - Award 8,900 171,842 5.46
2014-12-31 2014-12-29 4 BCRX BIOCRYST PHARMACEUTICALS INC
Stock Option (Right to Buy)
M - Exercise -9,500 111,135 -7.87
2014-12-31 2014-12-29 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
S - Sale -9,500 162,942 -5.51 12.56 -119,320 2,046,552
2014-12-31 2014-12-29 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
M - Exercise 9,500 172,442 5.83 3.78 35,910 651,831
2014-12-23 2014-12-19 4 BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
A - Award 17,000 17,000
2014-08-29 2014-08-27 4 BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
M - Exercise -10,000 7,000 -58.82
2014-08-29 2014-08-27 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
S - Sale -10,000 162,942 -5.78 13.58 -135,800 2,212,752
2014-08-29 2014-08-27 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
M - Exercise 10,000 172,942 6.14 5.45 54,500 942,534
2014-07-28 2014-07-25 4 BCRX BIOCRYST PHARMACEUTICALS INC
Stock Option (Right to Buy)
M - Exercise -26,455 120,635 -17.99
2014-07-28 2014-07-25 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
F - Taxes -8,504 162,252 -4.98 11.76 -100,007 1,908,084
2014-07-28 2014-07-25 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
M - Exercise 26,455 170,756 18.33 3.78 100,000 645,458
2014-07-02 2014-07-01 4 BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
M - Exercise X -3,125 15,500 -16.78
2014-07-02 2014-07-01 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
S - Sale X -3,125 144,301 -2.12 13.00 -40,625 1,875,913
2014-07-02 2014-07-01 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
M - Exercise 3,125 147,426 2.17 4.73 14,781 697,325
2014-06-24 2014-06-23 4 BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
M - Exercise X -3,125 18,625 -14.37
2014-06-24 2014-06-23 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
S - Sale X -3,125 144,301 -2.12 12.49 -39,031 1,802,319
2014-06-24 2014-06-23 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
M - Exercise 3,125 147,426 2.17 4.73 14,781 697,325
2014-06-19 2014-06-17 4 BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
M - Exercise X -3,125 21,750 -12.56
2014-06-19 2014-06-17 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
S - Sale X -3,125 144,301 -2.12 12.00 -37,500 1,731,612
2014-06-19 2014-06-17 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
M - Exercise 3,125 147,426 2.17 4.73 14,781 697,325
2014-05-28 2014-05-26 4 BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
A - Award 17,000 17,000
2014-05-27 2014-05-22 4 BCRX BIOCRYST PHARMACEUTICALS INC
Stock Option (Right to Buy)
M - Exercise -17,685 147,090 -10.73
2014-05-27 2014-05-22 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
M - Exercise 17,685 144,301 13.97 3.78 66,849 545,458
2014-03-17 2014-03-14 4 BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
M - Exercise -3,125 24,875 -11.16
2014-03-17 2014-03-14 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
S - Sale -3,125 126,616 -2.41 11.24 -35,125 1,423,164
2014-03-17 2014-03-14 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
M - Exercise 3,125 129,741 2.47 4.73 14,781 613,675
2014-03-07 2014-03-04 4 BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
M - Exercise -3,000 28,000 -9.68
2014-03-07 2014-03-04 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
S - Sale -3,000 126,616 -2.31 12.69 -38,070 1,606,757
2014-03-07 2014-03-04 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
M - Exercise 3,000 129,616 2.37 4.73 14,190 613,084
2014-03-07 2014-03-01 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
F - Taxes -461 126,616 -0.36 11.69 -5,389 1,480,141
2014-02-04 2014-01-20 4 BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
A - Award 35,000 35,000
2014-02-04 2014-01-20 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
A - Award 54,000 126,218 74.77
2014-01-15 2014-01-13 4 BCRX BIOCRYST PHARMACEUTICALS INC
Stock Option (Right to Buy)
M - Exercise -35,225 164,775 -17.61
2014-01-15 2014-01-13 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
F - Taxes -12,621 72,218 -14.88 10.55 -133,152 761,900
2014-01-15 2014-01-13 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
M - Exercise 35,225 84,839 71.00 3.78 133,150 320,691
2014-01-03 2014-01-01 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
F - Taxes -2,453 49,614 -4.71 7.60 -18,643 377,066
2013-03-14 2013-01-31 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
A - Award 2,745 52,609 5.50 1.38 3,788 72,600
2013-03-06 2013-03-01 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
F - Taxes -542 49,322 -1.09 1.19 -645 58,693
2013-01-07 2013-01-01 4 BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
A - Award 50,000 50,000
2013-01-07 2013-01-01 4 BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
A - Award 50,000 50,000
2013-01-07 2013-01-01 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
A - Award 8,500 49,864 20.55
2013-01-07 2013-01-01 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
A - Award 8,500 49,864 20.55
2012-07-02 2012-07-01 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
F - Taxes -8,113 31,617 -20.42 3.97 -32,209 125,519
2012-03-19 2012-03-15 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
F - Taxes -4,162 37,124 -10.08 5.23 -21,767 194,159
2012-03-19 2012-03-15 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
A - Award 11,989 41,286 40.92
2012-03-05 2012-03-01 4 BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
A - Award 31,000 31,000 4.73 146,630 146,630
2012-03-05 2012-03-01 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
A - Award 5,600 30,600 22.40
2011-07-08 3 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
25,000
P
Pasaran terbuka atau pembelian persendirian sekuriti bukan derivatif atau derivatif
S
Pasaran terbuka atau jualan persendirian sekuriti bukan derivatif atau derivatif
A
Pemberian, penganugerahan atau pemerolehan lain sekuriti daripada syarikat (seperti opsyen)
C
Penukaran derivatif
D
Penjualan atau pemindahan sekuriti kembali kepada syarikat
F
Pembayaran harga pelaksanaan atau liabiliti cukai menggunakan sebahagian daripada sekuriti yang diterima daripada syarikat
G
Hadiah sekuriti oleh atau kepada orang dalam
K
Swap ekuiti dan urus niaga lindung nilai yang serupa
M
Pelaksanaan atau penukaran sekuriti derivatif yang diterima daripada syarikat (seperti opsyen)
V
Transaksi dilaporkan secara sukarela pada Borang 4
J
Lain-lain (disertai dengan nota kaki yang menerangkan transaksi)